For citations:
Feist E, Fleischmann RM, Fatenejad S, Bukhanova D, Grishin S, Kuzkina S, Luggen M, Nasonov E, Samsonov M, Smolen JS. Olokizumab plus methotrexate: safety and efficacy over 106 weeks of treatment. Sovremennaya Revmatologiya=Modern Rheumatology Journal. 2024;18(6):21-35. (In Russ.) https://doi.org/10.14412/1996-7012-2024-6-21-35